Clinical Trials in New York State

Showing 15061-15080 of 17,167 trials

VI-1121 for the Treatment Alzheimer's Disease

NCT01428362

The purpose of this study is to determine whether VI-1121 is safe, well tolerated, and effective as a daily treatment for Alzheimer's disease that is worsening despite current treatment.

Alzheimer's Disease

VIVUS LLC61 participantsStarted Aug 2011

San Francisco, California, United States • Santa Monica, California, United States • Sunrise, Florida, United States +8 more locations

COMPLETEDPhase 369 miles

Eflornithine in Treating Patients With Bladder Cancer

NCT00003814

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if eflornithine is more effective than no further therapy in treating bladder cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of eflornithine in treating patients who have newly diagnosed or recurrent bladder cancer.

Bladder Cancer

National Cancer Institute (NCI)450 participantsStarted Feb 1999

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Anaheim, California, United States +58 more locations

VI-1121 for the Treatment Alzheimer's Disease

Eflornithine in Treating Patients With Bladder Cancer

Find Trials by Condition in New York State

Interventional Management of Stroke (IMS) III Trial

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology

Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)